Everest Medicines Ltd.(HK:1952)
HK$26.24-0.64 (-2.38%)
HK:1952
Everest Medicines Ltd. financials statements
HK$26.24
At close:-0.64 (-2.38%)
Want to see HK:1952 full AI Analyst Report?
Everest Medicines Ltd. (1952) Financial Statements
5 Followers
Everest Medicines Ltd. Financial Overview
Everest Medicines Ltd.'s market cap is currently ¥9.53B. The company's EPS TTM is ¥-0.16; its P/E ratio is -141.28; Everest Medicines Ltd. is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is ¥2.17. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 1.71B | ¥ 706.68M | ¥ 125.93M | ¥ 12.79M | ¥ 54.00K |
| Gross Profit | ¥ 1.18B | ¥ 528.89M | ¥ 91.52M | ¥ 8.15M | ¥ 31.00K |
| Operating Income | ¥ -386.24M | ¥ -1.12B | ¥ -932.74M | ¥ -256.80M | ¥ -1.03B |
| EBITDA | ¥ -187.37M | ¥ -646.59M | ¥ -744.63M | ¥ -198.91M | ¥ -972.78M |
| Net Income | ¥ -297.77M | ¥ -1.04B | ¥ -844.46M | ¥ -247.28M | ¥ -1.01B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 2.73B | ¥ 1.60B | ¥ 2.35B | ¥ 1.65B | ¥ 2.64B |
| Total Assets | ¥ 6.84B | ¥ 4.96B | ¥ 5.77B | ¥ 6.61B | ¥ 6.65B |
| Total Debt | ¥ 925.98M | ¥ 575.61M | ¥ 510.63M | ¥ 534.64M | ¥ 485.03M |
| Net Debt | ¥ -1.81B | ¥ -308.86M | ¥ -12.44M | ¥ 12.93M | ¥ -2.16B |
| Total Liabilities | ¥ 1.53B | ¥ 886.05M | ¥ 804.10M | ¥ 960.25M | ¥ 753.83M |
| Stockholders' Equity | ¥ 5.31B | ¥ 4.07B | ¥ 4.97B | ¥ 5.65B | ¥ 5.89B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -172.32M | ¥ -744.92M | ¥ -1.04B | ¥ -1.59B | ¥ -1.71B |
| Operating Cash Flow | ¥ -109.96M | ¥ -679.51M | ¥ -769.19M | ¥ -1.16B | ¥ -729.94M |
| Investing Cash Flow | ¥ -674.78M | ¥ 974.40M | ¥ 752.50M | ¥ -1.03B | ¥ -975.82M |
| Financing Cash Flow | ¥ 1.75B | ¥ 37.80M | ¥ 10.10M | ¥ -25.31M | ¥ -76.51M |
Currency in CNY
